“Outcome of 12-weeks Triple Therapy (TT), including Sofosbuvir (SOF), Ribavirin and Pegylated interferon-Alfa in all non-cirrhotic patients with chronic Hepatitis-C Genotype-3 infection”, mfm, vol. 28, no. 7, May 2024, Accessed: Nov. 16, 2025. [Online]. Available: https://medicalforummonthly.com/index.php/mfm/article/view/4148